Company
Neurizon Therapeutics Ltd
ASX:NUZ
Neurizon Therapeutics Limited is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. The company is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
2 stories